Skip to main content
Premium Trial:

Request an Annual Quote

Elena Hitraya

Crescendo Bioscience has appointed Elena Hitraya as chief medical officer, effective October 1. In this role, she will lead efforts to provide professional education initiatives, to expand market access for Vectra DA, and to develop the company's pipeline of autoimmune products. During the past 11 years, Hitraya has held leadership positions at Genentech, most recently as group medical director for rheumatology/immunology for the Genentech/Roche group. Prior to Genentech, she was regional director of medical affairs for immunology at Cenotocor, a divison of Johnson & Johnson.